Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy
Clinical trial NCT06619704 · COMPLETED
Trial details
- NCT number
- NCT06619704
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-10
- Primary completion
- 2023-09-27
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.